Taking a prescribed stimulant and using cocaine are different clinical issues, but they belong in the same medication review. A prescription may be treating ADHD or another diagnosed condition. Cocaine use may be intermittent, escalating, or part of an established substance use disorder. Neither fact should be hidden, and neither should automatically erase the other from the treatment plan.

The first step is to tell the prescribing clinician about cocaine use and arrange an individualized review. Do not increase, stop, substitute, or share medication on your own. The purpose of an honest discussion is to understand current benefit, possible risks, and what support is needed to address both the condition being treated and the cocaine use.

Separate the prescription from how it is being used

Bring the medication name, formulation, prescribed dose, schedule, start date, and prescriber’s contact details. Then describe what actually happens. Are doses taken as directed? Are some missed and others taken later? Has the amount changed without advice? Has anyone else’s medication been used? These details help the clinician distinguish treatment adherence, an ineffective regimen, and possible misuse.

The FDA’s stimulant safety communication emphasizes risks from misuse, sharing, addiction, and overdose. This does not mean that every person with an appropriate prescription has an addiction. It means the review needs accurate information about the product and the pattern, including behaviors that may feel embarrassing to mention.

Explain what the medication was intended to improve

Describe the original treatment goals: sustained attention, organization, impulsivity, daytime functioning, or another specific problem. Explain which areas improved and which remained difficult. A simple statement that the medication “works” or “does not work” can hide important differences between symptoms, side effects, and practical challenges.

For example, someone may concentrate better during meetings but still struggle with deadlines because sleep is disrupted and tasks are poorly organized. Another may take medication inconsistently because they dislike a particular effect. These are different problems with different possible responses. Bring previous reviews, assessment reports, or a brief account of changes since treatment began so the clinician can evaluate the prescription in context rather than treating cocaine use as the only relevant fact.

Do not use a response to cocaine as an ADHD test

Feeling calmer, more energetic, or more focused after a substance does not establish an ADHD diagnosis. The NIMH overview of ADHD describes assessment of a persistent pattern that affects functioning. A clinician considers developmental history, symptoms in different settings, and other possible explanations. An informal experiment with cocaine cannot provide that assessment.

If ADHD has never been formally evaluated, say so. If it has, ask whether the original report can be obtained. Useful history may include longstanding school or work difficulties, earlier treatment, and observations from someone who knew you before cocaine use began. The assessment should also consider sleep, mood, anxiety, and substance effects, because several difficulties can resemble attention problems or make an existing condition harder to manage.

Put cocaine use on the same timeline

Describe whether cocaine use began before or after the prescription, whether it occurs on medication days, and what usually precedes it. Note periods when prescribed treatment was stable and cocaine use was absent. Include changes in access, work patterns, travel, and other substances. Timing does not prove causation, but it helps a clinician ask better questions.

Avoid framing the conversation as a demand for either a stronger prescription or immediate discontinuation. A more useful starting point is: “Here is the pattern, here is what I am worried about, and here is what I need help functioning without.” Our guide to ADHD and cocaine assessment explores how the two concerns can be evaluated without collapsing them into a single explanation.

Bring physical symptoms into the discussion early

Tell the clinician about palpitations, chest discomfort, fainting, headaches, appetite changes, and sleep loss. Include relevant heart conditions, blood pressure history, and other medication. The prescriber decides what examination or monitoring is appropriate. Do not dismiss a symptom because it has happened before or because you are young, physically fit, or using a prescribed product as directed.

Chest pain, collapse, a seizure, severe agitation, or trouble breathing requires urgent medical help. The MedlinePlus information on cocaine intoxication describes serious possible complications. Tell emergency clinicians about both cocaine and prescription medication. A medication review for a stable person and an emergency assessment for current symptoms are different tasks, and one should not delay the other.

Include sleep products, alcohol, and other attempts to compensate

Some people respond to stimulation or sleep disruption by drinking or taking sedatives. Others take additional stimulants after a poor night because they need to work. If such a pattern exists, record it without trying to decide which step is the main cause. The review should include the whole sequence and any dependence or withdrawal concerns.

Bring over-the-counter products and supplements into the same conversation. A product marketed for focus, energy, or sleep can still matter to medication decisions. Do not assume that “natural” means irrelevant. Our combined substance history guide offers a way to organize this information. A pharmacist can help identify products, while the responsible prescriber should coordinate decisions about the treatment regimen.

Ask how care will remain connected

When an addiction clinician and an ADHD prescriber are both involved, establish who will communicate the agreed plan. Ask what information can be shared with your consent, who manages refills, and who reviews new symptoms. The objective is one consistent medication list and a clear route for advice rather than separate appointments that produce conflicting instructions.

The ASAM and AAAP guideline addresses stimulant use disorder alongside co-occurring conditions. For a patient, the practical implication is to ask how both concerns will be treated and monitored. A program should not simply tell you to conceal a prescription from another clinician or to stop established treatment without an appropriate review and explanation.

Understand what monitoring is meant to accomplish

If the team recommends more frequent appointments, pharmacy coordination, or another monitoring arrangement, ask its purpose and how it will be reviewed. A useful plan connects monitoring to a specific risk or treatment question. It should be clear what information is being collected, who sees it, and what result would lead to a change.

Discuss practical feasibility. A refill arrangement that cannot accommodate necessary travel or an appointment schedule that repeatedly conflicts with essential responsibilities may be difficult to sustain. That is a reason to plan carefully with the clinician, not to bypass the arrangement. Bring foreseeable obstacles up before medication runs out. Agree on a contact method for unexpected problems so that a disruption does not turn into unplanned self-medication.

If you find an instruction confusing, repeat back your understanding before leaving. Clarify whether the next contact is with the prescriber, addiction service, or pharmacist. Having a phone number is only useful when you know which question that service is responsible for answering.

Add support for the tasks medication does not solve alone

Even when medication helps, daily organization may require additional work. Discuss tools for remembering appointments, breaking tasks into manageable steps, protecting sleep, and recognizing situations that lead to cocaine use. Choose strategies that address an observed difficulty rather than adding an elaborate routine that becomes another source of failure or frustration.

For example, a person who repeatedly loses track of refills may need a simple reminder and a single pharmacy contact. Someone who works through the night may need a realistic stopping point and a discussion about workload. These are practical illustrations for a treatment conversation. They should complement clinical care, with cocaine treatment goals made explicit rather than assuming that improved attention will automatically prevent further use.

Make storage and sharing part of the plan

Keep prescription medication in accordance with its instructions and discuss secure storage when other people have access. Never share it with a colleague, partner, or friend, even if their symptoms sound similar. A medicine selected for one person is not an informal assessment or treatment option for someone else. Ask a pharmacist about disposal of unused medication.

If medication has been lost, borrowed, or shared, tell the prescriber accurately. The aim is to understand what happened and prevent a repeat, not to create a story that protects the appearance of perfect adherence. The FDA specifically warns about sharing prescription stimulants. A clear household boundary can reduce pressure while preserving the person’s legitimate access to treatment as agreed with their clinician.

Leave with a written, reviewable decision

At the end of the appointment, confirm the current medication instructions, the cocaine treatment plan, the next review date, and the symptoms that should prompt earlier contact. If a change is proposed, ask why, what benefit is expected, and how unwanted effects or declining functioning will be addressed. Keep a copy of the updated list for other treating professionals.

An effective review does not require choosing between honest disclosure and appropriate care for ADHD or another condition. It requires a plan that takes both seriously. As treatment progresses, bring new information back to the team: changes in use, sleep, functioning, adherence, and confidence in the plan. That makes the prescription part of coordinated care rather than an isolated issue managed separately from the cocaine concern.

Sources and further reading

Found a detail that has changed? Tell the editorial team.